IP Library Granted Patent US 9,428,806
Granted Patent B2
US 9,428,806 · App. 14/188,956 · Granted Aug 30, 2016

Apparatus and method for electrical detection of oligonucleotides through pore blockades

Inventors: Harold G. Monbouquette (Santa Monica, CA); Jacob J. Schmidt (Sherman Oaks, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
C12Q1/6869G01N33/48721
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,428,806
App. No.
14/188,956
Granted
Aug 30, 2016
Kind
B2
Abstract

Systems and methods for specific nucleic acid (NA) sequence detection that do not rely on polymerase chain reaction (PCR) for target sequence amplification and do not require any special reagents other than a complementary sequence capture probe conjugated to spherical beads.

Claims (32)

1. A method for detecting the presence of nucleic acids with a target sequence in a sample, the method comprising:

(a) providing a detection apparatus, said detection apparatus comprising:

(i) a first chamber;

(ii) a second chamber;

(iii) a membrane separating said first and second chambers, said membrane having one or more pores extending through the membrane between the first and second chambers;

(iv) a first electrode disposed in the first chamber; and

(v) a second electrode disposed in the second chamber;

(b) introducing a liquid into said first and second chambers;

(c) applying a direct electric current to said first and second electrodes with a negative polarity being connected to the first electrode;

(d) measuring electric current between the electrodes as a reference current;

(e) preparing at least one bead which is conjugated with one or more strands of capture probe nucleic acid that are complementary to a desired target sequence of a sample to be detected;

(f) capping charged groups on the prepared beads to render the beads with a neutral charge;

(g) introducing one or more of the capped beads and a sample into the first chamber to hybridize the capture probe to the desired target sequence; and

(h) detecting the target sequence by measuring electric current between the electrodes after introduction of the beads and sample and comparing the measured current with the reference current;

(i) wherein a decrease in measured electric current indicates the presence of one or more strands of target nucleic acid that are complementary to the probe sequence conjugated to the bead; and

(j) wherein said decrease in measured electric current results from electrophoretic movement of the beads bound to charged target nucleic acid strands to a pore of diameter less than the bead diameter or tapered to a lesser diameter and the beads causing sustained blockage of one or more pores.

2. A method as recited in claim 1 :

wherein each pore has a length between a first end and a second end;

wherein each pore has a diameter that decreases from said first end toward said second end;

wherein the beads have a diameter less than the diameter at the first end of the pore; and

wherein each pore has a diameter less than the diameter of the beads at a point along the length of the pore.

3. A method as recited in claim 1 , wherein each pore has a diameter ranging from approximately 10 nm to approximately 5 μm.

4. A method as recited in claim 1 , wherein each pore comprises an opening extending through said membrane.

5. A method as recited in claim 1 , wherein the pore comprises a pipette extending through said membrane.

6. A method as recited in claim 1 , wherein each bead comprises unmodified or functionalized polystyrene.

7. A method as recited in claim 6 , wherein each bead has a surface functionalized with amine or carboxyl groups to facilitate cross-linking to a terminal carboxyl or amine group, respectively, added to the terminus of nucleic acid capture probes.

8. A method as recited in claim 1 , wherein said strands of capture probe nucleic acid comprise peptide nucleic acids.

9. A method as recited in claim 1 , wherein the liquid comprises an electrolyte solution comprising approximately 0.01 M to approximately 1.0 M of an electrolyte in buffered water.

10. A method as recited in claim 9 , wherein said electrolyte is selected from the group comprising of NaCl, KCl, and other strong electrolytes.

11. A method as recited in claim 1 , further comprising:

creating a fluid flow through said membrane from the second chamber to the first chamber, said flow generated osmotically, electroosmotically or hydrostatically.

12. A method as recited in claim 1 , further comprising detecting the presence of a single nucleic acid molecule of a desired target sequence.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 10, 2016
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038949/0092 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2014
From: MONBOUQUETTE, HAROLD G.; SCHMIDT, JACOB J.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 032599/0396 →
Continuity (3)
Continuation PCTUS2012053540 · Aug 31, 2012
Provisional Application 61530349 · Sep 1, 2011
Related Publication 20140248711A1 · Sep 4, 2014